Global Thyroid Eye Disease Treatments Market by Drug (Corticosteroid, Monoclonal Antibody, Vitamin), Route of Administration (Oral, Topical), Treatment, Diagnosis, Distribution - Forecast 2024-2030- Product Image

Sale

Global Thyroid Eye Disease Treatments Market by Drug (Corticosteroid, Monoclonal Antibody, Vitamin), Route of Administration (Oral, Topical), Treatment, Diagnosis, Distribution - Forecast 2024-2030

Report
184 Pages
March 2024
Region: Global
360iResearch™
ID: 5012989

UP TO €850EUR$875USD£733GBP OFF until Dec 31^st 2024

The Thyroid Eye Disease Treatments Market size was estimated at USD 298.07 million in 2023, USD 326.24 million in 2024, and is expected to grow at a CAGR of 9.52% to reach USD 563.40 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Thyroid Eye Disease Treatments Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Thyroid Eye Disease Treatments Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Thyroid Eye Disease Treatments Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., AbbVie, Inc., Akron Inc., AMRI Global, Bausch & Lomb Incorporated, Bayer AG, Eyevance Pharmaceuticals LLC, F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, GlaxoSmithKline PLC, Horizon Therapeutics PLC, Immunovant, Inc., Kala Pharmaceuticals, Inc., Mabxience Research Sl, Merck KGaA, Pfizer Inc., RLC Labs, Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Viatris.

Market Segmentation & Coverage

This research report categorizes the Thyroid Eye Disease Treatments Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug
- Corticosteroid
- Monoclonal Antibody
- Vitamin
Route of Administration
- Oral
- Topical
Treatment
- Medication
- Radioactive Iodine Therapy
- Surgery
Diagnosis
- Blood Test
- Imaging Test
- Orbital Ultrasound
- Physical Exam
- Radioactive Iodine Uptake Test
Distribution
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Thyroid Eye Disease Treatments Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Thyroid Eye Disease Treatments Market?
What are the technology trends and regulatory frameworks in the Thyroid Eye Disease Treatments Market?
What is the market share of the leading vendors in the Thyroid Eye Disease Treatments Market?
Which modes and strategic moves are suitable for entering the Thyroid Eye Disease Treatments Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Thyroid Eye Disease Treatments Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High Prevalence of Autoimmune Diseases such as Grave’s Disease and Hashimoto's Thyroiditis
5.1.1.2. Awareness Raising National Health Programs Coupled with Favorable Reimbursement Policies related to Thyroid Disease Treatment
5.1.1.3. Increasing Iodine Disorder and Thyroid Tumors Screening
5.1.2. Restraints
5.1.2.1. Limited Accessibility, Affordability, and Unmeasured Side Effects
5.1.3. Opportunities
5.1.3.1. Improving Healthcare Infrastructure, Increasing Number of Ophthalmologists
5.1.3.2. Growing Early Diagnosis Rate Coupled with Developing Novel Therapy for the Thyroid Eye
5.1.4. Challenges
5.1.4.1. Limitation Associated with the Availability of any Definitive Thyroid Eye Treatment
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Thyroid Eye Disease Treatments Market, by Drug

6.1. Introduction
6.2. Corticosteroid
6.3. Monoclonal Antibody
6.4. Vitamin

7. Thyroid Eye Disease Treatments Market, by Route of Administration

7.1. Introduction
7.2. Oral
7.3. Topical

8. Thyroid Eye Disease Treatments Market, by Treatment

8.1. Introduction
8.2. Medication
8.3. Radioactive Iodine Therapy
8.4. Surgery

9. Thyroid Eye Disease Treatments Market, by Diagnosis

9.1. Introduction
9.2. Blood Test
9.3. Imaging Test
9.4. Orbital Ultrasound
9.5. Physical Exam
9.6. Radioactive Iodine Uptake Test

10. Thyroid Eye Disease Treatments Market, by Distribution

10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy

11. Americas Thyroid Eye Disease Treatments Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Thyroid Eye Disease Treatments Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Thyroid Eye Disease Treatments Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

15.1. Key Company Profiles
15.1.1. Abbott Laboratories Inc.
15.1.2. AbbVie, Inc.
15.1.3. Akron Inc.
15.1.4. AMRI Global
15.1.5. Bausch & Lomb Incorporated
15.1.6. Bayer AG
15.1.7. Eyevance Pharmaceuticals LLC
15.1.8. F. Hoffmann-La Roche AG
15.1.9. Fujifilm Holdings Corporation
15.1.10. GlaxoSmithKline PLC
15.1.11. Horizon Therapeutics PLC
15.1.12. Immunovant, Inc.
15.1.13. Kala Pharmaceuticals, Inc.
15.1.14. Mabxience Research Sl
15.1.15. Merck KGaA
15.1.16. Pfizer Inc.
15.1.17. RLC Labs
15.1.18. Sanofi S.A.
15.1.19. Teva Pharmaceutical Industries Ltd.
15.1.20. Viatris
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

List of Figures

FIGURE 1. THYROID EYE DISEASE TREATMENTS MARKET RESEARCH PROCESS
FIGURE 2. THYROID EYE DISEASE TREATMENTS MARKET SIZE, 2023 VS 2030
FIGURE 3. THYROID EYE DISEASE TREATMENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. THYROID EYE DISEASE TREATMENTS MARKET DYNAMICS
FIGURE 7. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
FIGURE 8. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 12. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
FIGURE 14. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 16. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. THYROID EYE DISEASE TREATMENTS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. THYROID EYE DISEASE TREATMENTS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. THYROID EYE DISEASE TREATMENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. THYROID EYE DISEASE TREATMENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 6. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY VITAMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 10. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 13. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY RADIOACTIVE IODINE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 17. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY IMAGING TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORBITAL ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY PHYSICAL EXAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 23. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 42. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 43. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 45. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 46. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 47. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 48. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 50. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 51. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 69. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 70. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 73. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 74. INDIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 75. INDIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. INDIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. INDIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 78. INDIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 84. JAPAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 85. JAPAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. JAPAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. JAPAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 88. JAPAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 114. THAILAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 115. THAILAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. THAILAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 117. THAILAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 118. THAILAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 131. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 133. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 134. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 135. EGYPT THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 136. EGYPT THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. EGYPT THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 138. EGYPT THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 139. EGYPT THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 140. FINLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 141. FINLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. FINLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 143. FINLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 144. FINLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 145. FRANCE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 146. FRANCE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 147. FRANCE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 148. FRANCE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 149. FRANCE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 150. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 151. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 152. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 153. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 154. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 160. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 161. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 162. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 163. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 164. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 175. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 176. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 178. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 179. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 180. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 181. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 183. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 184. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 185. QATAR THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 186. QATAR THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. QATAR THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 188. QATAR THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 189. QATAR THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 205. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 206. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 208. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 209. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 220. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 221. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 222. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 223. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 224. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 235. THYROID EYE DISEASE TREATMENTS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 236. THYROID EYE DISEASE TREATMENTS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 237. THYROID EYE DISEASE TREATMENTS MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories Inc.
AbbVie, Inc.
Akron Inc.
AMRI Global
Bausch & Lomb Incorporated
Bayer AG
Eyevance Pharmaceuticals LLC
F. Hoffmann-La Roche AG
Fujifilm Holdings Corporation
GlaxoSmithKline PLC
Horizon Therapeutics PLC
Immunovant, Inc.
Kala Pharmaceuticals, Inc.
Mabxience Research Sl
Merck KGaA
Pfizer Inc.
RLC Labs
Sanofi S.A.
Teva Pharmaceutical Industries Ltd.
Viatris

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	184
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 326.24 Million
Forecasted Market Value ( USD ) by 2030	$ 563.4 Million
Compound Annual Growth Rate	9.5%
Regions Covered	Global
No. of Companies Mentioned	20

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3277EUR$3,374USD£2,827GBP €3641EUR$3,749USD£3,141GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4151EUR$4,274USD£3,581GBP €4613EUR$4,749USD£3,979GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5025EUR$5,174USD£4,335GBP €5584EUR$5,749USD£4,817GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5900EUR$6,074USD£5,089GBP €6555EUR$6,749USD£5,655GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7648EUR$7,874USD£6,598GBP €8498EUR$8,749USD£7,331GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Thyroid Eye Disease Treatment Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global Thyroid Eye Disease (TED) Treatment Market (2023 Edition): Analysis By Therapeutic Type, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

Graves' Disease - Pipeline Insight, 2024

Thyroid Gland Disorder Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

Thyroid Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

About the Thyroid Eye Disease Treatment Market